PSGL-1 Protein Purification Using Three-Step Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying recombinant PSGL-1 proteins are inadequate for achieving high purity suitable for in vivo applications and are not scalable for industrial use, particularly due to issues with contaminant removal and column leakage.
Innovation Solution
A three-step chromatographic process involving strong anion exchange, hydrophobic interaction, and hydroxyapatite chromatography is employed, using specific buffers and salt concentrations to achieve high purity and scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If affinity chromatography with antibodies or Protein A is used, then purification selectivity and purity are improved, but the risk of ligand leakage and immunogenicity increases
Solution Approach 1:
The patent extracts and removes the harmful affinity ligands (antibodies or Protein A) from the purification system by replacing them with non-immunogenic alternative ligands that can still specifically bind to the target protein, thereby eliminating ligand leakage and immunogenicity risks while maintaining purification selectivity
Solution Approach 2:
The patent introduces intermediary substances (alternative ligands) that mediate the binding between the stationary phase and the target protein, replacing the problematic antibodies or Protein A with intermediaries that provide the same separation function without causing immunogenicity or leakage issues
2Ease of manufacture
If conventional purification methods are used, then processing is simpler, but achieving high purity suitable for in vivo applications is insufficient
Solution Approach 1:
The patent segments the purification process into multiple sequential chromatography steps, each targeting specific contaminants (DNA, proteins, endotoxins), thereby achieving high purity suitable for in vivo applications while maintaining reasonable process complexity through systematic division of purification tasks
Solution Approach 2:
The patent utilizes parameter changes in chromatography conditions (pH, ionic strength, temperature) to optimize the separation efficiency at each purification step, enabling high purity recovery while maintaining process feasibility for industrial scale-up
3Productivity
If high density cell growth is used to increase protein expression, then production yield is improved, but contaminating proteins and cellular debris increase
Solution Approach 1:
The patent converts the harmful effect of high cell density (increased contaminants) into a benefit by designing a purification system that specifically targets and removes these contaminants through sequential chromatography steps, thereby enabling high productivity while achieving high purity through systematic contaminant elimination
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a purity level suitable for in vivo uses by effectively removing DNA and other proteins, enabling large-scale production of recombinant PSGL-1 proteins.
Implementation Method 1
a) a strong anion exchange column chromatography
Implementation Method 2
b) a hydrophobic interaction column chromatography
Implementation Method 3
c) a hydroxyapatite column chromatography
Data Source
AI summary
The present invention discloses a method for the purification of highly acidic recombinant proteins. The acidic protein is preferably the extracellular region of PSGL-1 or fusion and/or chimeric proteins comprising this soluble portion. Purification is a three-steps chromatography which comprises separation on an Anion Exchange solid-phase, a Hydrophobic Interaction and a Hydroxyapatite. Purity and yields are optimal and the process can be easily scaled up and automated.